Blue Sparrow’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.67M Buy
+110,100
New +$7.73M 0.08% 133

Other funds holding NKTR

Blue Sparrow's NKTR Position: Q3 2026 in Review

Blue Sparrow opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 110,100 shares worth $6.67M. The stake represents 0.08% of the portfolio and ranks #133 among its holdings.

243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Blue Sparrow held 110,100 shares of Nektar Therapeutics worth $6.67M as of Q3 2026.
  • Nektar Therapeutics was a new Blue Sparrow position in Q3 2026.
  • Nektar Therapeutics made up 0.08% of Blue Sparrow's portfolio in Q3 2026, its #133 holding.
  • 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Blue Sparrow's 13F filing for Q3 2026, filed 16 Nov 2026.